Nephrocare Health Services Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nephrocare Health Services Limited (Nephroplus) submitted a routine compliance certificate to BSE and NSE on April 10, 2026. The certificate, issued by KFIN Technologies Limited (the company's Registrar and Share Transfer Agent), confirms that details of securities dematerialized and rematerialized during Q4 (January-March 2026) were properly furnished to both depositories - CDSL and NSDL. This is a standard quarterly regulatory filing required under SEBI regulations to ensure proper tracking of share dematerialization/rematerialization activities. No specific securities movements or issues were highlighted in this filing.
This is a routine compliance filing with no direct impact on the company's financial position or stock price. It simply confirms the company is meeting its regulatory obligations regarding securities management.